| Product NDC: | 53329-301 | 
| Proprietary Name: | Chlorhexidine Gluconate | 
| Non Proprietary Name: | Chlorhexidine Gluconate | 
| Active Ingredient(s): | .12 mg/mL & nbsp; Chlorhexidine Gluconate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | RINSE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 53329-301 | 
| Labeler Name: | Medline Industries, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077789 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100805 | 
| Package NDC: | 53329-301-61 | 
| Package Description: | 80 BOTTLE in 1 CASE (53329-301-61) > 15 mL in 1 BOTTLE (53329-301-24) | 
| NDC Code | 53329-301-61 | 
| Proprietary Name | Chlorhexidine Gluconate | 
| Package Description | 80 BOTTLE in 1 CASE (53329-301-61) > 15 mL in 1 BOTTLE (53329-301-24) | 
| Product NDC | 53329-301 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Chlorhexidine Gluconate | 
| Dosage Form Name | RINSE | 
| Route Name | ORAL | 
| Start Marketing Date | 20100805 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Medline Industries, Inc. | 
| Substance Name | CHLORHEXIDINE GLUCONATE | 
| Strength Number | .12 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Decreased Cell Wall Integrity [PE] |